Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
C for the price for the amount of product you actually get
Your provider can assess baseline inflammatory markers if clinically indicated and monitor changes over time, though routine inflammatory marker testing is not standard practice for tirzepatide therapy
For any target anchor dose D (mg) and anchor mass M in the vial (GHK-Cu = 50 mg, BPC-157 = 10 mg): V water = V draw M D Worked example 3 mg GHK-Cu, 20-unit (0.2 mL) draw: V water = 0.2 mL 50 mg3 mg = 3.33 mL BAC water The GLOW Calculator above solves this for any anchor and draw volume
Interactions : Stimulants, BP/diabetes meds, MAOIs
This dual anti-inflammatory and pro-survival signaling complements the gene-level anti-inflammatory effects of GHK-Cu and the vascular protection afforded by BPC-157's nitric oxide production, creating coordinated suppression of destructive inflammation while preserving protective immune responses essential for optimal tissue repair
